The content provided in this video is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All views expressed are those of InsightfulValue and are based on publicly available information believed to be reliable, but no guarantee is made as to its accuracy or completeness. Always conduct your own research or consult a licensed financial advisor before making any investment decisions. Investing in the stock market involves risks, including the loss of principal.
Please be aware that the stock prices displayed on this website represent a curated selection of data. On desktop devices, you will see a wider range of stock prices, while on mobile devices, we provide a more streamlined view for better user experience and readability.
Our focus is on assessing a company's overall value and performance, rather than analyzing price fluctuations, even if we do watch prices in order to find companies trading below their intrinsic value. For more detailed charting and comprehensive market analysis, we recommend consulting a professional financial service or utilizing advanced charting tools.
We strive to provide accurate and timely information, but we encourage you to verify any financial data before making investment decisions.
Overview
Hikma Pharmaceuticals is a global pharmaceutical company headquartered in London, United Kingdom. It was founded in 1978 in Amman, Jordan and has since expanded its operations to over 50 countries, with a strong presence in the Middle East, North Africa, and the United States. Hikma is a leading company in generic and branded pharmaceuticals, serving patients in a wide range of therapeutic areas including respiratory, oncology, infectious diseases, and cardiovascular diseases. The company also has a portfolio of over 1000 branded products, including over-the-counter medications, Hikma-branded generics, and specialty, injectable, and biosimilar products. Hikma is committed to providing affordable and high-quality medications to people around the world. The company's mission is to help people live better and healthier lives by providing essential medicines and healthcare products. Hikma has a strong focus on research and development, investing a significant portion of its revenue into developing new products and improving existing ones. The company also works closely with healthcare professionals and patients to understand their needs and develop innovative solutions. Hikma is also dedicated to sustainability and ethical business practices. The company has implemented numerous initiatives to reduce its environmental impact and ensure responsible sourcing and manufacturing processes. Overall, Hikma Pharmaceuticals is a well-respected and established global pharmaceutical company with a strong commitment to improving global health and access to affordable medicines.
👉 InsightfulValue is a platform for public company analysis.
👉 We provide a database of public companies, with a focus on value investing principles.
👉 We carefully select every company in our database. With only 1988 listed, there's a reason for that.
👉 The reason is simple – we only select the best-performing public companies, true champions. And we know exactly what we mean by "champion."
👉 For us, a champion is a company with strong finances, a history of impressive dividends, great management, and standout products or services. We mean it.
👉 For each company, we have 464 questions and answers covering every aspect of their market position and operations. Everything.
👉 ... plus additional 98 Q&A about the industry each company operates in.
InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations. Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site. By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.
